BlackRock, Inc. 13D and 13G filings for Ocugen, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Ocugen, Inc. OCGN |
BlackRock Inc. BLK |
18,614,758 6.500% |
0 (Unchanged) |
Filing |
2024-10-22 6:06 pm Purchase |
2024-09-30 | 13G | Ocugen, Inc. OCGN |
BlackRock Inc. BLK |
18,614,758 6.500% |
14,707,344![]() (+376.40%) |
Filing |
2023-07-07 4:35 pm Sale |
2023-06-30 | 13G | Ocugen, Inc. OCGN |
BlackRock Inc. BLK |
3,907,414 1.500% |
-11,153,947![]() (-74.06%) |
Filing |
2023-01-31 5:52 pm Purchase |
2022-12-31 | 13G | Ocugen, Inc. OCGN |
BlackRock Inc. BLK |
15,061,361 6.900% |
2,130,230![]() (+16.47%) |
Filing |
2022-02-04 4:26 pm Purchase |
2021-12-31 | 13G | Ocugen, Inc. OCGN |
BlackRock Inc. BLK |
12,931,131 6.500% |
12,931,131![]() (New Position) |
Filing |